Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 3

İlk epizod psikoz olgularında serum neopterin ve haptoglobulin düzeyleri

Serum neopterin and haptoglobin concentrations in patients with first episode psychosis

Pages
192–195
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that SANS, SAPS and BPRS scores were not associated with serum haptoglobin and neopterin concentrations in the patient group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: There is some evidence that acute episode of psychosis is characterized by immune alterations, but there are conflicting results about this issue.
📊
Key Findings & Data:Methods: Forty-six male patients with first episode psychosis and 52 healthy subjects were included in this study.
💡
Conclusion & Impact:It was found that SANS, SAPS and BPRS scores were not associated with serum haptoglobin and neopterin concentrations in the patient group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: There is some evidence that acute episode of psychosis is characterized by immune alterations, but there are conflicting results about this issue. The aim of this study was to determine whether serum haptoglobin and neopterin concentrations in patients with first episode psychosis are different from those in control subjects. Methods: Forty-six male patients with first episode psychosis and 52 healthy subjects were included in this study. Psychotic symptoms were assessed by using the Scale for the Assessment of Negative Symptoms (SANS), Scale for the Assessment of Positive Symptoms (SAPS) and the Brief Psychiatric Rating Scale (BPRS). All patients were drug naive, and serum neopterin and haptoglobin concentrations were measured. Results: We found that in the first episode psychosis group, serum neopterin concentrations were higher than in the control group. However, there was no difference between the two groups in terms of serum haptoglobin concentrations. It was found that SANS, SAPS and BPRS scores were not associated with serum haptoglobin and neopterin concentrations in the patient group. Discussion: Our results show that cellular immune response was elevated in first episode psychosis, but these findings were not associated with the severity of the disease.

Özet

Amaç: Akut psikotik epizodun immün değişikliklerle ilişkili olduğuna dair bazı bulgular saptanmış olmakla birlikte bu konudaki bulgular çelişkilidir. Bu çalışmada ilk epizod psikoz hastalarının serum neopterin ve haptoglobulin düzeylerinin sağlıklı kontrol grubundan farklı olup olmadığının saptanması amaçlanmıştır. Yön tem: İlk epizod psikoz hastası 46 olgu ve 52 sağlıklı olgu çalışmaya alındı. Psikotik semptomlar Negatif Semptomları Değerlendirme Ölçeği (NSDÖ), Pozitif Semptomları Değerlendirme Ölçeği (PSDÖ) ve Kısa Psikiyatrik Derecelendirme Ölçeği (KPDÖ) ile değerlendirildi. Tüm hastalar ilaçsızdı ve serum neopterin ve haptoglobulin düzeyleri ölçüldü. Bulgular: İlk epizod psikoz olgularında serum neopterin düzeyinin sağlıklı kontrol grubundan yüksek olduğu saptandı. Bununla birlikte iki grup arasında serum haptoglobulin düzeyleri yönünden farklılık saptanmadı. FEP grubunda serum neopterin ve haptoglobulin düzeyleri ile NSDÖ, PSDÖ ve KPDÖ puanları arasında bağıntı saptanmadı. Sonuç: Çalışmanın bulguları ilk epizod psikozda hücresel bağışıklık yanıtının artmış olduğunu ancak bu bulgunun hastalık şiddeti ile ilişkili olmadığını göstermektedir.

🔖

Cite This Article

ERDEM, M., ÇELİK, C., YAMAN, H., DORUK, A., UZUN, Ö., BALIKÇI, A., ÇAYCI, T., KURT, Y. G., ÖZDEMİR, B. (2012). İlk epizod psikoz olgularında serum neopterin ve haptoglobulin düzeyleri. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 3, 192–195. https://ajindex.com/articles/292631

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Maes M, Delanghe J, Bocchio Chiavetto L, Bignotti S, Tura GB, Pioli R, Zanardini R, Altamura CA. Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16. Psychiatry Res 2001
  2. Ahokas A. Immunoglobulin and C3 abnormalities in acute psychiatric disorders. Acta Psychiatr Scand 1986
  3. Frommberger UH, Bauer J, Haselbauer P, Fräulin A, Riemann D, Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 1997
  4. Ganguli R, Yang Z, Shurin G, Chengappa KN, Brar JS, Gubbi AV, Rabin BS. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 1994
  5. Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R, Bosmans E, Pioli R, Altamura C, Scharpé S, Maes M. The infammatory response system in treatment- resistant schizophrenia: Increased serum interleukin-6. Schizophr Res 1998
  6. Maes M, Meltzer HY, Bosmans E. Immune-infammatory markers in schizophrenia: Comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 1994
  7. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and Interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood-stabilizers. J Psychiatr Res 1995
  8. Maes M, Bosmans E, Ranjan R, Vandoolaeghe E, Meltzer HY, De Ley M, Berghmans R, Stans G, Desnyder R. Lower plasma CC16, a natural anti infammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophr Res 1996
  9. Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpé S. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 1997
  10. Monteleone P, Fabrazzo M, Tortorella A, Maj M. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: Effects of clozapine treatment. Psychiatry Res 1997
  11. Naudin J, Mège JL, Azorin JM, Dassa D. Elevated circulating levels of IL 6 in schizophrenia. Schizophr Res 1996
  12. Sirota P, Schild K, Elizur A, Djaldetti M, Fishman P. Increased interleukin 1 and interleukin-3 like activity in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 1995
  13. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swe